Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocannabinoids | 8 | 2025 | 44 | 2.390 |
Why?
|
| Interneurons | 7 | 2025 | 147 | 1.920 |
Why?
|
| Synaptic Transmission | 6 | 2024 | 365 | 1.800 |
Why?
|
| CA1 Region, Hippocampal | 4 | 2024 | 81 | 1.650 |
Why?
|
| Synapses | 7 | 2024 | 470 | 1.190 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2021 | 174 | 1.140 |
Why?
|
| Pyramidal Cells | 5 | 2021 | 172 | 1.000 |
Why?
|
| Hippocampus | 11 | 2025 | 861 | 0.950 |
Why?
|
| Receptor, Cannabinoid, CB1 | 7 | 2024 | 30 | 0.910 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2024 | 28 | 0.900 |
Why?
|
| Signal Transduction | 7 | 2025 | 4922 | 0.610 |
Why?
|
| Neuronal Plasticity | 5 | 2024 | 288 | 0.500 |
Why?
|
| Microscopy | 2 | 2016 | 123 | 0.490 |
Why?
|
| Molecular Imaging | 1 | 2015 | 65 | 0.470 |
Why?
|
| Receptors, Cannabinoid | 1 | 2014 | 10 | 0.460 |
Why?
|
| Cholecystokinin | 2 | 2025 | 14 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 616 | 0.400 |
Why?
|
| Mice | 16 | 2024 | 18936 | 0.380 |
Why?
|
| Neurons | 6 | 2022 | 2050 | 0.370 |
Why?
|
| Neuroimaging | 1 | 2014 | 376 | 0.360 |
Why?
|
| Presynaptic Terminals | 4 | 2024 | 83 | 0.360 |
Why?
|
| Animals | 20 | 2025 | 36222 | 0.350 |
Why?
|
| Software | 1 | 2015 | 735 | 0.350 |
Why?
|
| Seizures | 3 | 2024 | 889 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 4823 | 0.270 |
Why?
|
| Parvalbumins | 3 | 2022 | 36 | 0.250 |
Why?
|
| Axons | 2 | 2021 | 397 | 0.250 |
Why?
|
| Brain Waves | 1 | 2024 | 48 | 0.210 |
Why?
|
| Receptors, Nicotinic | 1 | 2024 | 158 | 0.200 |
Why?
|
| Behavior, Animal | 1 | 2025 | 522 | 0.190 |
Why?
|
| Hypothalamus, Posterior | 1 | 2021 | 1 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2024 | 253 | 0.190 |
Why?
|
| Nerve Net | 1 | 2025 | 262 | 0.190 |
Why?
|
| Islands of Calleja | 1 | 2021 | 2 | 0.190 |
Why?
|
| Locomotion | 1 | 2021 | 64 | 0.180 |
Why?
|
| Amnesia | 1 | 2020 | 18 | 0.170 |
Why?
|
| Mammals | 1 | 2021 | 282 | 0.170 |
Why?
|
| Cognition | 1 | 2024 | 819 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2524 | 0.140 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2016 | 13 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3979 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 399 | 0.130 |
Why?
|
| Male | 10 | 2024 | 65939 | 0.130 |
Why?
|
| Epilepsy | 1 | 2024 | 897 | 0.120 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2015 | 43 | 0.120 |
Why?
|
| Brain | 3 | 2021 | 3223 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2015 | 176 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 46 | 0.120 |
Why?
|
| Biological Transport | 1 | 2015 | 367 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2015 | 168 | 0.110 |
Why?
|
| Cannabinoids | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 437 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 366 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 678 | 0.100 |
Why?
|
| Cannabinoid Receptor Modulators | 2 | 2015 | 7 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2014 | 824 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1728 | 0.090 |
Why?
|
| Neural Inhibition | 2 | 2024 | 110 | 0.080 |
Why?
|
| Action Potentials | 2 | 2024 | 521 | 0.080 |
Why?
|
| Female | 5 | 2024 | 71840 | 0.080 |
Why?
|
| Rats | 3 | 2021 | 3851 | 0.080 |
Why?
|
| Algorithms | 1 | 2015 | 1736 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2008 | 209 | 0.070 |
Why?
|
| Dronabinol | 1 | 2024 | 33 | 0.050 |
Why?
|
| Memory Consolidation | 1 | 2024 | 12 | 0.050 |
Why?
|
| Piperidines | 2 | 2016 | 241 | 0.050 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2024 | 59 | 0.050 |
Why?
|
| Arousal | 1 | 2024 | 82 | 0.050 |
Why?
|
| Nicotinic Agonists | 1 | 2024 | 45 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2024 | 86 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 2024 | 84 | 0.050 |
Why?
|
| Pyrazoles | 2 | 2016 | 334 | 0.050 |
Why?
|
| Calcium | 1 | 2008 | 1100 | 0.050 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2021 | 8 | 0.050 |
Why?
|
| Theta Rhythm | 1 | 2021 | 24 | 0.050 |
Why?
|
| Substance P | 1 | 2021 | 38 | 0.050 |
Why?
|
| Spatial Navigation | 1 | 2021 | 23 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2021 | 47 | 0.050 |
Why?
|
| Wakefulness | 1 | 2022 | 104 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 103 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2020 | 103 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2021 | 283 | 0.040 |
Why?
|
| Piperazines | 1 | 2021 | 256 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2020 | 102 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2020 | 163 | 0.040 |
Why?
|
| Hypoxia | 1 | 2020 | 267 | 0.040 |
Why?
|
| Cell Body | 1 | 2016 | 3 | 0.030 |
Why?
|
| Benzoxazines | 1 | 2016 | 23 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2016 | 37 | 0.030 |
Why?
|
| Morpholines | 1 | 2016 | 64 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2016 | 74 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 141 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 300 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 117 | 0.030 |
Why?
|
| Glycerides | 1 | 2015 | 16 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 2015 | 29 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 455 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 250 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1303 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 606 | 0.020 |
Why?
|
| Phospholipase D | 1 | 2008 | 7 | 0.020 |
Why?
|
| Humans | 2 | 2024 | 133811 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2008 | 45 | 0.020 |
Why?
|